Saiyed Atiq Raza Sells 41,439 Shares of Arteris, Inc. (NASDAQ:AIP) Stock

Arteris, Inc. (NASDAQ:AIP - Get Free Report) Director Saiyed Atiq Raza sold 41,439 shares of the firm's stock in a transaction that occurred on Thursday, December 26th. The stock was sold at an average price of $10.37, for a total transaction of $429,722.43. Following the transaction, the director now directly owns 690,121 shares of the company's stock, valued at approximately $7,156,554.77. This trade represents a 5.66 % decrease in their ownership of the stock. The sale was disclosed in a filing with the Securities & Exchange Commission, which is available at this hyperlink.

Saiyed Atiq Raza also recently made the following trade(s):

• On Wednesday, December 18th, Saiyed Atiq Raza sold 12,166 shares of Arteris stock. The stock was sold at an average price of $10.07, for a total value of $122,511.62.
• On Wednesday, December 11th, Saiyed Atiq Raza sold 2,400 shares of Arteris stock. The shares were sold at an average price of $10.01, for a total value of $24,024.00.

Arteris Trading Up 0.8 %

AIP traded up $0.08 during trading on Monday, hitting $10.35. The company's stock had a trading volume of 261,787 shares, compared to its average volume of 169,906. Arteris, Inc. has a twelve month low of $4.83 and a twelve month high of $10.69. The stock has a market cap of $415.83 million, a PE ratio of -10.78 and a beta of 1.25. The firm's 50 day moving average price is $8.56 and its 200-day moving average price is $7.97. The company has a debt-to-equity ratio of 0.30, a current ratio of 1.16 and a quick ratio of 1.16.

Institutional Investors Weigh In On Arteris

A number of hedge funds and other institutional investors have recently made changes to their positions in the business. US Bancorp DE acquired a new stake in Arteris in the 3rd quarter worth about $34,000. The Manufacturers Life Insurance Company acquired a new stake in shares of Arteris in the second quarter worth approximately $86,000. Algert Global LLC purchased a new stake in Arteris in the second quarter valued at approximately $115,000. MetLife Investment Management LLC raised its stake in Arteris by 129.1% during the third quarter. MetLife Investment Management LLC now owns 16,951 shares of the company's stock worth $131,000 after purchasing an additional 9,551 shares during the period. Finally, Dynamic Technology Lab Private Ltd acquired a new position in shares of Arteris in the 3rd quarter valued at $226,000. Hedge funds and other institutional investors own 64.36% of the company's stock.

Analysts Set New Price Targets

Separately, Rosenblatt Securities reissued a "buy" rating and issued a $15.00 target price on shares of Arteris in a research note on Wednesday, November 6th.

About Arteris

Arteris, Inc provides semiconductor interconnect intellectual property (IP) and System-on-Chip (Soc) Integration Automation software solutions (SIA) in the Americas, the Asia Pacific, Europe, and the Middle East. The company develops, licenses, and supports the on-chip interconnect fabric technology used in Soc designs and Network-on-Chip (NoC) interconnect IP.